Characterization of the TREM-1 signaling landscape in human neutrophils
PLOS One · 05.03.2026 · 21 (3) · e0334007
DOI: 10.1371/journal.pone.0334007 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 05.03.2026. Verfasst von Frederic Ries und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Medical Oncology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany. Hauptthemen laut MEDLINE: Triggering Receptor Expressed on Myeloid Cells-1, Signal Transduction, Neutrophils, Receptors, Immunologic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
The Triggering Receptor Expressed on Myeloid Cells (TREM)-1 is a member of the Immunoglobulin superfamily, and an activating receptor mainly expressed on myeloid cells. Beyond its role in acute and chronic inflammatory processes, TREM-1 is also involved in cancer emergence and progression probably by alteration of the tumor-associated neutrophils (TAN) and macrophages (TAM). Advanced information about the TREM-1 signaling cascade may reveal novel targets for treating inflammatory and cancer diseases. As many specific kinase inhibitors are approved for treating various diseases, targeting kinases being active after TREM-1 ligation serves as a promising approach. Therefore, we investigated the protein tyrosine kinome (PTK) and serine threonine kinome (STK) by kinome activity profiling of purified human neutrophils after TREM-1 activation. As TREM-1 interacts with Toll-like receptor (TLR) 4 signaling, we used TLR4-activation by LPS to define TREM-1 specific pathways. We found an increased kinome activity after receptor ligation and could predict individual kinases. To gain further insights into the signaling cascade, we additionally investigated the transcriptomic profile that made us available to link the kinome activity to the resulting transcriptomic profile. In sum, we revealed several signaling pathways being active after TREM-1 ligation that are associated with various biological processed and diseases. This study facilitates selecting kinase inhibitors for further validation with the aim of targeting TREM-1 signaling in various inflammatory or cancer disease conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Hematology and Medical Oncology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
- Institute for Immunology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
- Research Center for Immunotherapy (FZI), Mainz, Germany.
- Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
- Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School (MHH), Hannover, Germany.
- Leibniz-Institute on Aging, Fritz-Lipmann-Institute, Jena, Germany.
ORCID-Profile: Sophie Többen, Federico Marini, Markus P Radsak
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Ries, F., Klein, M., Rogmann, N., Többen, S., Marini, F., Heidel, F., & Radsak, M. P. (2026). Characterization of the TREM-1 signaling landscape in human neutrophils. PLOS One, 21(3), e0334007. https://doi.org/10.1371/journal.pone.0334007
Vancouver
Ries F, Klein M, Rogmann N, Többen S, Marini F, Heidel F, et al. Characterization of the TREM-1 signaling landscape in human neutrophils. PLOS One. 2026;21(3):e0334007. doi:10.1371/journal.pone.0334007
BibTeX
@article{Ries2026,
author = {Ries, Frederic and Klein, Matthias and Rogmann, Nora and Többen, Sophie and Marini, Federico and Heidel, Florian and Radsak, Markus P},
title = {Characterization of the TREM-1 signaling landscape in human neutrophils},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {3},
pages = {e0334007},
doi = {10.1371/journal.pone.0334007}
}
EUVIMED